- Home
- CATO vs ARMP Comparison
CATO vs ARMP Comparison
Compare CATO & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- ARMP
- Stock Information
- Founded
- CATO 1946
- ARMP N/A
- Country
- CATO United States
- ARMP United States
- Employees
- CATO N/A
- ARMP N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CATO Consumer Discretionary
- ARMP Health Care
- Exchange
- CATO Nasdaq
- ARMP Nasdaq
- Market Cap
- CATO 59.2M
- ARMP 52.1M
- IPO Year
- CATO N/A
- ARMP N/A
- Fundamental
- Price
- CATO $2.86
- ARMP $2.25
- Analyst Decision
- CATO
- ARMP Strong Buy
- Analyst Count
- CATO 0
- ARMP 1
- Target Price
- CATO N/A
- ARMP $9.00
- AVG Volume (30 Days)
- CATO 32.4K
- ARMP 18.4K
- Earning Date
- CATO 08-21-2025
- ARMP 08-12-2025
- Dividend Yield
- CATO 6.05%
- ARMP N/A
- EPS Growth
- CATO N/A
- ARMP N/A
- EPS
- CATO N/A
- ARMP N/A
- Revenue
- CATO $642,949,000.00
- ARMP $4,699,000.00
- Revenue This Year
- CATO N/A
- ARMP $8.43
- Revenue Next Year
- CATO N/A
- ARMP N/A
- P/E Ratio
- CATO N/A
- ARMP N/A
- Revenue Growth
- CATO N/A
- ARMP 14.24
- 52 Week Low
- CATO $2.19
- ARMP $0.90
- 52 Week High
- CATO $6.70
- ARMP $3.42
- Technical
- Relative Strength Index (RSI)
- CATO 64.69
- ARMP 63.56
- Support Level
- CATO $2.84
- ARMP $1.93
- Resistance Level
- CATO $3.05
- ARMP $2.24
- Average True Range (ATR)
- CATO 0.14
- ARMP 0.16
- MACD
- CATO 0.02
- ARMP 0.03
- Stochastic Oscillator
- CATO 100.00
- ARMP 104.55
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.